IRGACARE^®† MP-Coated Plus Sutures

SSIs are a risk to millions
worldwide

How can IRGACARE^® MP help address a risk factor commonly
associated with infections in a surgical setting?

• Plus Sutures with IRGACARE^® MP eliminate certain bacteria on the suture and create a zone of inhibition proven in in vitro studies^1,3

• In vitro studies have confirmed that IRGACARE^® MP actively inhibits colonization on the suture on all Plus Sutures by the pathogens most commonly associated with SSIs^1,3:
   - Staphylococcus aureus
   - Staphylococcus epidermidis
   - Methicillin-resistant Staphylococcus aureus (MRSA)
   - Methicillin-resistant Staphylococcus epidermidis (MRSE)
• MONOCRYL Plus Sutures and PDS Plus Sutures also inhibit the colonization of^1,3:
   - Escherichia coli
   - Klebsiella pneumoniae

What is the impact of IRGACARE^® MP on the use of Plus Sutures?

• Plus Sutures with IRGACARE^® MP have demonstrated the same strength, performance, and integrity as other Ethiconsynthetic absorbable sutures⁴
   - Ease of passage, tie down, and surgical handling are maintained
   - Wound healing response, bursting strength, and absorption rates are not compromised⁵

Learn more about PROTECTION>